Liraglutide preserves CD34+ stem cells from dysfunction Induced by high glucose exposure.
Sforza A, Vigorelli V, Rurali E, Perrucci GL, Gambini E, Arici M, Metallo A, Rinaldi R, Fiorina P, Barbuti A, Raucci A, Sacco E, Rocchetti M, Pompilio G, Genovese S, Vinci MC.
Sforza A, et al. Among authors: vigorelli v.
Cardiovasc Diabetol. 2022 Apr 9;21(1):51. doi: 10.1186/s12933-022-01486-9.
Cardiovasc Diabetol. 2022.
PMID: 35397526
Free PMC article.